Peapack Gladstone Financial Corp Decreases Stake in UnitedHealth Group Incorporated $UNH

Peapack Gladstone Financial Corp reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 53,358 shares of the healthcare conglomerate’s stock after selling 1,426 shares during the quarter. Peapack Gladstone Financial Corp’s holdings in UnitedHealth Group were worth $17,614,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Virtue Asset Management LLC increased its holdings in UnitedHealth Group by 20.7% in the 4th quarter. Virtue Asset Management LLC now owns 2,212 shares of the healthcare conglomerate’s stock worth $730,000 after buying an additional 379 shares during the period. PARUS FINANCE UK Ltd increased its holdings in UnitedHealth Group by 15.9% in the 4th quarter. PARUS FINANCE UK Ltd now owns 28,110 shares of the healthcare conglomerate’s stock worth $9,279,000 after buying an additional 3,850 shares during the period. Verity & Verity LLC acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $1,065,000. Texas Yale Capital Corp. increased its holdings in UnitedHealth Group by 78.6% in the 4th quarter. Texas Yale Capital Corp. now owns 6,200 shares of the healthcare conglomerate’s stock worth $2,047,000 after buying an additional 2,728 shares during the period. Finally, Impact Partnership Wealth LLC boosted its position in UnitedHealth Group by 15.9% in the 4th quarter. Impact Partnership Wealth LLC now owns 2,525 shares of the healthcare conglomerate’s stock worth $834,000 after purchasing an additional 347 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.28% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Weiss Ratings upgraded UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Morgan Stanley upped their price objective on UnitedHealth Group from $375.00 to $395.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 22nd. Erste Group Bank upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, April 27th. TD Cowen upped their price objective on UnitedHealth Group from $311.00 to $337.00 and gave the stock a “hold” rating in a research report on Thursday, April 23rd. Finally, HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective on the stock in a research report on Tuesday, April 7th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $397.63.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealthcare said it will eliminate prior authorization requirements for nearly two-thirds of pediatric services by year-end. That could reduce administrative friction, improve patient/provider relations, and support customer satisfaction. Reuters article
• Positive Sentiment: Bernstein raised its price target on UNH to $492 from $444 and kept an Outperform rating, citing an EPS recovery outlook. Higher price targets from analysts can help reinforce investor confidence. Yahoo Finance article
• Neutral Sentiment: Berkshire Hathaway fully exited its UNH stake, which is drawing attention to valuation and regulatory risks. While not necessarily a fundamental change, the sale may weigh on sentiment around the stock. Yahoo Finance article
• Negative Sentiment: Massachusetts filed a lawsuit against a UnitedHealth insurance unit, alleging more than $100 million in Medicaid fraud tied to inflated illness severity claims. The lawsuit adds legal and reputational risk for UNH. Investing.com article

UnitedHealth Group Stock Down 0.2%

NYSE UNH opened at $379.70 on Monday. The business has a fifty day moving average price of $336.85 and a 200 day moving average price of $321.55. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $404.15. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. The company has a market cap of $344.82 billion, a P/E ratio of 28.68, a P/E/G ratio of 1.64 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same period in the prior year, the company earned $7.20 EPS. The firm’s revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 18.29 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.